NCT05766345View on ClinicalTrials.gov

BCG-induced Epigenetic Modifications in the NEXT Generation

PHASE4Active, not recruitingINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

October 2, 2023

Primary Completion Date

August 31, 2024

Study Completion Date

October 31, 2024

Conditions
Trained ImmunityBCG VaccineEpigenetics
Interventions
BIOLOGICAL

BCG-Vaccine SSI [Statens Serum Institut]) Danish strain 1331

Nothing to add

BIOLOGICAL

Placebo

Nothing to add

Trial Locations (1)

6525AG

Radboudumc, Nijmegen

All Listed Sponsors
lead

Radboud University Medical Center

OTHER

NCT05766345 - BCG-induced Epigenetic Modifications in the NEXT Generation | Biotech Hunter | Biotech Hunter